HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and evaluation of Tc-99m-labeled RRL-containing peptide as a non-invasive tumor imaging agent in a mouse fibrosarcoma model.

AbstractOBJECTIVE:
Arginine-arginine-leucine (RRL) is considered a tumor endothelial cell-specific binding sequence. RRL-containing peptide targeting tumor vessels is an excellent candidate for tumor imaging. In this study, we developed RRL-containing hexapeptides and evaluated their feasibility as a tumor imaging agent in a HT-1080 fibrosarcoma-bearing murine model.
METHODS:
The hexapeptide, glutamic acid-cysteine-glycine (ECG)-RRL was synthesized using Fmoc solid-phase peptide synthesis. Radiolabeling efficiency was evaluated using instant thin-layer chromatography. Uptake of Tc-99m ECG-RRL within HT-1080 cells was evaluated in vitro by confocal microscopy and cellular binding affinity was calculated. Gamma images were acquired In HT-1080 fibrosarcoma tumor-bearing mice, and the tumor-to-muscle uptake ratio was calculated. The inflammatory-to-normal muscle uptake ratio was also calculated in an inflammation mouse model. A biodistribution study was performed to calculate %ID/g.
RESULTS:
A high yield of Tc-99m ECG-RRL complexes was prepared after Tc-99m radiolabeling. Binding of Tc-99m ECG-RRL to tumor cells had was confirmed by in vitro studies. Gamma camera imaging in the murine model showed that Tc-99m ECG-RRL accumulated substantially in the subcutaneously engrafted tumor and that tumoral uptake was blocked by co-injecting excess RRL. Moreover, Tc-99m ECG-RRL accumulated minimally in inflammatory lesions.
CONCLUSIONS:
We successfully developed Tc-99m ECG-RRL as a new tumor imaging candidate. Specific tumoral uptake of Tc-99m ECG-RRL was evaluated both in vitro and in vivo, and it was determined to be a good tumor imaging candidate. Additionally, Tc-99m ECG-RRL effectively distinguished between cancerous tissue and inflammatory lesions.
AuthorsDae-Weung Kim, Woo Hyoung Kim, Myoung Hyoun Kim, Chang Guhn Kim
JournalAnnals of nuclear medicine (Ann Nucl Med) Vol. 29 Issue 9 Pg. 779-85 (Nov 2015) ISSN: 1864-6433 [Electronic] Japan
PMID26179963 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Oligopeptides
  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • technetium 99m Glu-Cys-Gly-Arg-Arg-Leu
Topics
  • Animals
  • Cell Line, Tumor
  • Disease Models, Animal
  • Female
  • Fibrosarcoma (diagnostic imaging, metabolism, pathology)
  • Gamma Cameras
  • Humans
  • Mice, Inbred BALB C
  • Mice, Nude
  • Microscopy, Confocal
  • Molecular Structure
  • Muscles (diagnostic imaging, metabolism)
  • Neoplasm Transplantation
  • Oligopeptides (chemical synthesis, chemistry, pharmacokinetics)
  • Organotechnetium Compounds (chemical synthesis, chemistry, pharmacokinetics)
  • Radionuclide Imaging
  • Radiopharmaceuticals (chemical synthesis, chemistry, pharmacokinetics)
  • Whole Body Imaging

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: